Prosecution Insights
Last updated: April 19, 2026
Application No. 18/368,766

OPTICAL MEMBER AND METHOD FOR PRODUCING SAME

Non-Final OA §102§103
Filed
Sep 15, 2023
Examiner
FREEMAN, JOHN D
Art Unit
1787
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Kaneka Corporation
OA Round
1 (Non-Final)
46%
Grant Probability
Moderate
1-2
OA Rounds
3y 11m
To Grant
53%
With Interview

Examiner Intelligence

Grants 46% of resolved cases
46%
Career Allow Rate
339 granted / 738 resolved
-19.1% vs TC avg
Moderate +7% lift
Without
With
+6.9%
Interview Lift
resolved cases with interview
Typical timeline
3y 11m
Avg Prosecution
41 currently pending
Career history
779
Total Applications
across all art units

Statute-Specific Performance

§101
0.2%
-39.8% vs TC avg
§103
46.4%
+6.4% vs TC avg
§102
18.4%
-21.6% vs TC avg
§112
28.1%
-11.9% vs TC avg
Black line = Tech Center average estimate • Based on career data from 738 resolved cases

Office Action

§102 §103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Election/Restrictions Applicant’s election without traverse of Invention I, claims 1-7 and 12-18, in the reply filed on 10/15/2025 is acknowledged. Claims 8-11 and 19 are withdrawn from further consideration pursuant to 37 CFR 1.142(b) as being drawn to a nonelected invention, there being no allowable generic or linking claim. Election was made without traverse in the reply filed on 10/15/2025. Claim Rejections - 35 USC § 102 Claim(s) 1-4, 6-7, 12-13, and 15-16 is/are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Kawabata et al. (US 2008/0318072). Regarding claim 1: Kawabata discloses an imide resin for optical uses [abstract; 0001; 0039]. An article can be formed by injection molding [0124; 0227]. The resin comprises a unit according to General Formula (1), a unit according to General Formula (2), and a unit according to General Formula (3), which correspond to the presently claimed General Formulas (1)-(3) [0040-0043]. The resin has the following properties: An orientation birefringence is -0.1×10-3 to 0.1×103 [0040]; A photoelastic constant has an absolute value of 5×10-12 Pa-1 or less [0103-0104]; A glass transition temperature is 130°C or more [0101]; and A phase difference (retardation) of 20 nm or less [0167]. Examples 15 and 18 disclose imide resins having photoelastic constants of 2×10-12 Pa-1 and 1×10-12 Pa-1 and glass transition temperatures of 132°C and 159°C, respectively [0298-0306; 0305; 0321-0328; 0327; Tables 3 & 5]. Regarding claim 2: Given that Kawabata discloses a resin that is otherwise the same as claimed, the examiner submits the prior art resin necessarily meets the same property requirements as claimed. Regarding claims 3 and 12: Kawabata teaches the imidization ratio is 5-70% [0223]. Various examples disclose ratios falling within the claimed ranges, including, but not limited to: Example 1 is 68%; Example 5 is 65%; Example 6 is 45%; Example 15 is 58%, and Example 18 is 69% [Tables 1, 3, and 5]. Regarding claims 4 and 13: Kawabata teaches R3 is preferably a methyl group [0089]. Additionally, Example 15 has an imidization ratio of 58% and uses monomethylamine in forming the resin (i.e., results in R3 is a methyl group) [0298]. Regarding claims 6 and 15: Given that Kawabata discloses a resin that is otherwise the same as claimed, the examiner submits the prior art resin necessarily meets the same property requirements as claimed. Regarding claims 7 and 16: Kawabata discloses lenses and displays [0107]. Claim(s) 5 and 14 is/are rejected under 35 U.S.C. 102(a)(1) as anticipated by or, in the alternative, under 35 U.S.C. 103 as obvious over Kawabata et al. (US 2008/0318072). Regarding claims 5 and 14: Kawabata teaches an optical article comprising a glutarimide resin as explained above. Imidization ratios falling within the claimed range are disclosed as explained in rejections above, which are incorporated herein by reference. Kawabata teaches R3 is a hydrogen atom or a methyl group and further teaches units comprising different groups can be used [0089]. The examiner submits this disclosure is sufficiently specific to anticipate the claimed glutarimide units. Alternatively, the examiner also submits such a combination of groups would have been obvious in view of the disclosure. Before the effective filing date of the claimed invention, it would have been obvious to one of ordinary skill in the art to use a unit wherein R3 is hydrogen and a unit wherein R3 is methyl to provide a glutarimide resin in accordance with Kawabata’s teaching, and thereby arrive at the claimed invention. Claim(s) 1-2, 6-7, and 15-18 is/are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Yoshida et al. (JP 2020-015905). Note: citations refer to the machine translation of JP ‘905 provided with this Office Action. Regarding claim 1: Yoshida a methacrylic resin and an injection-molded optical component formed therefrom [abstract; 0001; 0008]. The resin comprises (A) a unit derived from a methacrylic acid ester monomer, (B-2) a unit comprising glutarimide, and (C) a unit derived from a vinyl monomer [0014]. Unit (A) is formed from monomers falling within the scope of present General Formula (2), such as methyl methacrylate, ethyl methacrylate, etc. [0016]. Unit (B-2) comprises a glutarimide represented by General Formula (3), which corresponds to present General Formula (1) [0027-0028]. Unit (C) is formed from aromatic vinyl monomers (C-1), such as those represented by General Formula (5), falling within the scope of present General Formula (3) [0033-0034]. The resin has the following properties: An orientation birefringence has an absolute value of 0.1×10-5 to 5.0×10-5 [0052]; A photoelastic constant has an absolute value of 3.0×10-12 Pa-1 or less [0058]; A glass transition temperature is 125°C or more [0050]; and A retardation of 5.0 nm or less or 4.0 nm or less (note the machine translation incorrectly translates the upper limit as “5.1mm or less” but the subsequent values clarify the units) [0151; also see original JP ‘905 at 0151]. Regarding claim 2: Given that Yoshida discloses a resin that is otherwise the same as claimed, the examiner submits the prior art resin necessarily meets the same property requirements as claimed. Regarding claims 6 and 15: Given that Yoshida discloses a resin that is otherwise the same as claimed, the examiner submits the prior art resin necessarily meets the same property requirements as claimed. Regarding claims 7 and 16: Yoshida teaches lens and in-vehicle displays [0153]. Regarding claims 17-18: Yoshida teaches thicknesses of up to 1.5 mm [0152]. Yoshida also teaches the use of test pieces having thicknesses of 1 mm and 4 mm [0162-0163]. Claim Rejections - 35 USC § 103 Claim(s) 17-18 is/are rejected under 35 U.S.C. 103 as being unpatentable over Kawabata et al. (US 2008/0318072) in view of Yoshida et al. (JP 2020-015905). Note: citations refer to the machine translation of JP ‘905 provided with this Office Action. Regarding claims 17 and 18: Kawabata teaches an optical article comprising a glutarimide resin as explained above. Kawabata discloses lenses and displays [0107]. Kawabata is silent with regard to the thickness of such articles. Lenses and other optical articles having thicknesses within the claimed range were known in the art. For example, Yoshida discloses a methacrylic resin composition useful for optical articles, such as lenses and displays [abstract; 0001; 0153]. The resin comprises a unit comprising a methacrylic acid ester, a unit comprising a glutarimide, and a unit comprising a vinyl component [0014]. Yoshida provides an injection molded article having a thickness of up to 1.5 mm [0057; 0146; 0152]. As set forth in MPEP 2144.05, in the case where the claimed range “overlap or lie inside ranges disclosed by the prior art”, a prima facie case of obviousness exists, In re Wertheim, 541 F.2d 257, 191 USPQ 90 (CCPA 1976); In re Woodruff, 919 F.2d 1575, 16 USPQ2d 1934 (Fed. Cir. 1990). Before the effective filing date of the claimed invention, it would have been obvious to one of ordinary skill in the art to vary the thickness of the optical article over values known in the art to have utility, including values falling within the claimed range, to provide such useful optical articles. Claim(s) 3-5 and 12-14 is/are rejected under 35 U.S.C. 103 as being unpatentable over Yoshida et al. (JP 2020-015905). Note: citations refer to the machine translation of JP ‘905 provided with this Office Action. Regarding claims 3 and 12: Yoshida teaches the content of the glutarimide-based structural unit is 5-70% by mass, preferably 5-60% by mass of the methacrylic resin to provide the desired glass transition temperature [0028]. As set forth in MPEP 2144.05, in the case where the claimed range “overlap or lie inside ranges disclosed by the prior art”, a prima facie case of obviousness exists, In re Wertheim, 541 F.2d 257, 191 USPQ 90 (CCPA 1976); In re Woodruff, 919 F.2d 1575, 16 USPQ2d 1934 (Fed. Cir. 1990). Before the effective filing date of the claimed invention, it would have been obvious to one of ordinary skill in the art to vary the imidization ration, including values falling within the claimed range, to provide the desired glass transition temperature for a given end use. Regarding claims 4 and 13: Yoshida teaches a glutarimide represented by General Formula (3) having R9, which corresponds to present General Formula (1) having R3, wherein R9 is a methyl group [0028]. Yoshida teaches the content of the glutarimide-based structural unit is 5-70% by mass, preferably 5-60% by mass of the methacrylic resin to provide the desired glass transition temperature [0028]. As set forth in MPEP 2144.05, in the case where the claimed range “overlap or lie inside ranges disclosed by the prior art”, a prima facie case of obviousness exists, In re Wertheim, 541 F.2d 257, 191 USPQ 90 (CCPA 1976); In re Woodruff, 919 F.2d 1575, 16 USPQ2d 1934 (Fed. Cir. 1990). Before the effective filing date of the claimed invention, it would have been obvious to one of ordinary skill in the art to vary the imidization ratio, including values falling within the claimed range, to provide the desired glass transition temperature for a given end use. Regarding claims 5 and 14: See the rejection of claims 4 and 13 regarding the claimed imidization ratio. Yoshida teaches a glutarimide represented by General Formula (3) having R9, which corresponds to present General Formula (1) having R3, wherein R9 is a hydrogen atom or methyl group and further teaches units comprising different groups can be used [0028]. The examiner submits this disclosure is sufficiently specific to anticipate the claimed glutarimide units. Alternatively, the examiner also submits such a combination of groups would have been obvious in view of the disclosure. Before the effective filing date of the claimed invention, it would have been obvious to one of ordinary skill in the art to use a unit wherein R9 is hydrogen and a unit wherein R9 is methyl to provide a glutarimide resin in accordance with Yoshida’s teaching, and thereby arrive at the claimed invention. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to JOHN D FREEMAN whose telephone number is (571)270-3469. The examiner can normally be reached Monday-Friday 11-8PM EST. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Callie Shosho can be reached at 571-272-1123. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /JOHN D FREEMAN/Primary Examiner, Art Unit 1787
Read full office action

Prosecution Timeline

Sep 15, 2023
Application Filed
Jan 23, 2026
Non-Final Rejection — §102, §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12589581
THIN FILM CAPACITOR
2y 5m to grant Granted Mar 31, 2026
Patent 12577357
POLYIMIDE-BASED RESIN FILM, SUBSTRATE FOR DISPLAY DEVICE, AND OPTICAL DEVICE USING THE SAME
2y 5m to grant Granted Mar 17, 2026
Patent 12521965
SEALED MULTILAYER STRUCTURES AND PACKAGES COMPRISING SEALED MULTILAYER STRUCTURES
2y 5m to grant Granted Jan 13, 2026
Patent 12522704
POLYIMIDE FILM HAVING HIGH DIMENSIONAL STABILITY AND MANUFACTURING METHOD THEREFOR
2y 5m to grant Granted Jan 13, 2026
Patent 12516490
MULTILAYER MEMBRANE FOR CONSTRUCTION
2y 5m to grant Granted Jan 06, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

1-2
Expected OA Rounds
46%
Grant Probability
53%
With Interview (+6.9%)
3y 11m
Median Time to Grant
Low
PTA Risk
Based on 738 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month